CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $724,556
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$724,556. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-18 | Barry Richard President & CEO | Purchase | +44,851 | $0.52 | $23K | 1,955,947 |
| 2026-11-17 | Barry Richard President & CEO | Purchase | +132,926 | $0.48 | $64K | 1,911,096 |
| 2026-11-16 | Barry Richard President & CEO | Purchase | +440,206 | $0.47 | $207K | 1,778,170 |
| 2026-09-30 | Barry Richard President & CEO | Purchase | +100,000 | $0.92 | $92K | 1,337,964 |
| 2026-09-29 | Barry Richard President & CEO | Purchase | +206,813 | $0.90 | $186K | 1,237,964 |
| 2026-09-28 | Barry Richard President & CEO | Purchase | +93,091 | $0.84 | $78K | 1,031,151 |
| 2025-11-20 | Barry Richard President & CEO | Purchase | +150,000 | $2.76 | $414K | 938,060 |
| 2025-11-19 | Barry Richard President & CEO | Purchase | +73,385 | $2.75 | $202K | 788,060 |
| 2025-09-22 | Barry Richard President & CEO | Purchase | +7,172 | $2.28 | $16K | 714,675 |
| 2025-09-19 | Barry Richard President & CEO | Purchase | +400 | $2.25 | $900 | 660,595 |
| 2025-09-19 | Barry Richard President & CEO | Purchase | +46,908 | $2.29 | $107K | 707,503 |
| 2025-09-18 | Barry Richard President & CEO | Purchase | +5,400 | $2.13 | $12K | 474,962 |
| 2025-09-18 | Barry Richard President & CEO | Purchase | +185,233 | $2.24 | $415K | 660,195 |
| 2025-04-17 | Barry Richard President & CEO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2024-10-01 | Barry Richard President & CEO | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2024-05-09 | Barry Richard Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-04-23 | Barry Richard Director | Exercise or conversion | +176,085 | $22.00 | $3.9M | 469,562 |
| 2024-04-23 | Barry Richard Director | Exercise or conversion · Common Stock Warrant | −117,390 | 0 | ||
| 2024-01-03 | Barry Richard Director | Grant or award · Common Stock Warrant | +117,390 | 176,085 | ||
| 2023-08-22 | Barry Richard Director | Purchase | +16,571 | $16.65 | $276K | 293,477 |
Page 1 of 2 · 26 trades